1314985-57-3 Usage
Uses
Used in Pharmaceutical Industry:
Tert-Butyl 3-ethoxyazetidine-1-carboxylate is utilized as a key intermediate in the synthesis of various pharmaceuticals due to its ability to participate in multiple chemical reactions, facilitating the creation of a broad spectrum of medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, tert-Butyl 3-ethoxyazetidine-1-carboxylate serves as a crucial building block for the development of new agrochemicals, contributing to the advancement of crop protection and enhancement of agricultural productivity.
Used in Organic Synthesis:
Tert-Butyl 3-ethoxyazetidine-1-carboxylate is employed as a versatile intermediate in organic synthesis for the preparation of a diverse array of fine chemicals, highlighting its adaptability in chemical reactions to produce complex organic molecules.
Used in Research and Development:
tert-Butyl 3-ethoxyazetidine-1-carboxylate is also used as a research tool in academic and industrial laboratories, where it aids in the exploration of new chemical pathways and the development of innovative synthetic methods, further expanding the horizons of chemical science and technology.
Check Digit Verification of cas no
The CAS Registry Mumber 1314985-57-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,9,8 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1314985-57:
(9*1)+(8*3)+(7*1)+(6*4)+(5*9)+(4*8)+(3*5)+(2*5)+(1*7)=173
173 % 10 = 3
So 1314985-57-3 is a valid CAS Registry Number.
1314985-57-3Relevant academic research and scientific papers
4-OXO-3,4-DIHYDROQUINAZOLINON COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS
-
Page/Page column 0260, (2021/12/31)
The invention relates to a compound represented by formula I: or a pharmaceutically acceptable salt thereof, formula wherein R1,R2,R3,R4,R5,R6,R7 and L are as defined in the description, for the treatment of diseases and conditions associated with BRAF, including tumors associated with BRAF.
